TMJ Disorders: Future Innovations in Diagnostics and Therapeutics

Predicting the Uncertain Future of Aptamer-Based Diagnostics and Therapeutics.

Despite the great promise of nucleic acid aptamers in the areas of diagnostics and therapeutics for their facile in vitro development, lack of immunogenicity and other desirable properties, few truly successful aptamer-based products exist in the clinical or other markets. Core reasons for these commercial deficiencies probably stem from industrial commitment to antibodies including a huge fina...

Gold Nanoparticles in Molecular Diagnostics and Therapeutics

Multifunctional nanoparticles, which incorporate diagnostic (quantum dots, magnetic, metallic, polymeric and silica nanoparticles) and/or therapeutic (magnetic and metallic nanoparticles) properties, are in the process of development. They have been used in vivo to protect the drug entity in the systemic circulation, restrict access of the drug to the chosen sites and to deliver the drug at a c...

Iron deficiency: what are the future trends in diagnostics and therapeutics?

A review of currently available diagnostic and therapeutic modalities for the laboratory assessment of iron deficiencies has identified a need for novel markers to complement the traditional serum iron, ferritin, and transferrin measurements and to improve the assessment of the best therapeutic options for treating these disorders. Newer markers, such as serum transferrin receptor and reticuloc...

Why disruptive innovations matter in laboratory diagnostics.

In the modern era, advances in clinical laboratory screening and diagnostic tests have had a profound impact in improving the quality and value of medical care (1, 2 ). Today, laboratory diagnostic tests can inform physicians and patients of the exact causes of a number of diseases and disorders, including cancer, chronic diseases, infectious diseases, sexually transmitted diseases, and genetic...

Supramolecular Nanoparticles for Molecular Diagnostics and Therapeutics